Greater reduction seen in mortality with bariatric surgery than GLP-1 RAs

Bariatric metabolic surgery (BMS) is associated with a greater reduction in mortality than glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment among adults with a diabetes duration of 10 years or less, according to a study published online June 7 in JAMA Network Open.

This article was originally published on

You may also be interested in:

Read More:

Lawyers Lookup